Scholar Rock Holding Corporation (SRRK) vs TransMedics Group, Inc. (TMDX)

A side-by-side comparison of Scholar Rock Holding Corporation and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 3, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnSRRK vs TMDX

growth of $100 · dividends reinvested · last 7y
SRRK +167.3% (+15.1%/yr)TMDX +277.0% (+20.9%/yr)TMDX compounded faster over this window
0200400600800Start $100202120232025$267$377
SRRK TMDX

SRRK vs TMDX: by the numbers

  • SRRK is the larger company ($6.70B vs $3.01B market cap).
  • TMDX is profitable (22.69% net margin) while SRRK runs a net loss (0.00%).
  • SRRK grew revenue faster over the past five years (110.77% vs 86.12% CAGR).

Metrics side by side

Valuation

MetricSRRKTMDX
P/E ratioN/A21.84
Forward P/EN/A56.34
P/S ratioN/A5.13
P/B ratio28.876.62
EV / EBITDAN/A32.42
FCF yieldN/A2.30%

Profitability

MetricSRRKTMDX
Gross margin0.00%58.69%
Operating margin0.00%12.21%
Net margin0.00%22.69%
ROE-161.00%29.28%
ROIC-90.04%5.87%

Growth (annualized)

MetricSRRKTMDX
Revenue CAGR (5Y)110.77%86.12%
Total return CAGR (5Y)7.65%20.20%

Frequently asked

Which has grown faster, SRRK or TMDX?
Over the past five years, SRRK grew revenue faster — SRRK at a 110.77% CAGR versus TMDX at 86.12%.
Is SRRK or TMDX more profitable?
TMDX runs the higher net margin — SRRK at 0.00% versus TMDX at 22.69%.
How have SRRK and TMDX total returns compared?
Over the past 5 years, SRRK delivered 7.65% and TMDX delivered 20.20% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 3, 2026.